Current Consultations

Research Australia regularly contributes to the policy discussions on issues pertinent to Health and Medical Research. This can be through submissions or participating in consultations.

The following list is of consultations and invitations to make submissions which are relevant to health and medical research and/or health policy in Australia. Research Australia may not participate in every one however the list is updated regularly.

If you would like more information or you are aware of other consultations that should be included, please contact Greg Mullins, Head of Policy, Research Australia at greg.mullins@researchaustralia.org or on (03) 9662 9420.

Consultation Details
ADOPTION OF EU GUIDELINES IN AUSTRALIA

 

Due 18 APRIL

Several EU guidelines recommended for adoption or non-adoption by the TGA are open for comment on whether they should be adopted in Australia.
SA HEALTH – RESEARCH FOCUS 2020

 

Due 21 APRIL

SA Health is consulting publicly on its draft Research Focus 2020 document on the future research focus for SA Health.

The draft ‘has been developed following extensive consultation with the South Australian health and medical research sector.’

PROVISIONAL APPROVAL PATHWAY FOR PRESCRIPTION MEDICINES: REGISTRATION AND POST MARKET REQUIREMENTS

 Due 1 May

The TGA is seeking comments from interested parties on the proposed Provisional Approval registration process and post market requirements for provisionally registered medicines.

A public consultation paper on the proposal is available on the website.

STRENGTHENING MONITORING OF MEDICINES IN AUSTRALIA

 Due 1 May

The TGA is seeking comments from interested parties on the proposed enhancements to the safety monitoring of medicines in Australia.

A public consultation paper on the proposal is available on the website.

 

OPTIONS FOR THE FUTURE REGULATION OF LOW RISK PRODUCTS

Due 12 May

In March 2015, the Expert Review of Medicines and Medical Devices Regulation (MMDR) made three recommendations to conduct further reviews of the regulation of ‘low risk’ products in Australia. This approach was supported by Government in its broader consideration of MMDR implementation.

The TGA is seeking submissions in response to a public consultation paper which contains a range of options for the future regulation of ‘low risk’ therapeutic goods (including maintenance of the status quo).

2030 STRATEGIC PLAN FOR INNOVATION, SCIENCE AND RESEARCH

Due 31May

The Australian Government has tasked Innovation and Science Australia with developing a Strategic Plan for the Australian innovation, science and research system out to 2030.

It will describe what Australia’s innovation system should look like in 2030 and will make recommendations as to how Australia can get there.

Innovation and Science Australia has released an Issues Paper which nominates six challenges central to shaping the strategy and is seeking feedback.